These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22202228)

  • 21. Biomonitoring equivalents for hexachlorobenzene.
    Aylward LL; Hays SM; Gagné M; Nong A; Krishnan K
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):25-32. PubMed ID: 20547196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative interpretation of human biomonitoring data.
    Clewell HJ; Tan YM; Campbell JL; Andersen ME
    Toxicol Appl Pharmacol; 2008 Aug; 231(1):122-33. PubMed ID: 18589468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human milk biomonitoring data: interpretation and risk assessment issues.
    LaKind JS; Brent RL; Dourson ML; Kacew S; Koren G; Sonawane B; Tarzian AJ; Uhl K
    J Toxicol Environ Health A; 2005 Oct; 68(20):1713-69. PubMed ID: 16176917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling mixtures resulting from concurrent exposures to multiple sources.
    Arnold SF; Price PS;
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):121-4. PubMed ID: 17258780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reconstructing exposures from biomarkers using exposure-pharmacokinetic modeling--A case study with carbaryl.
    Brown K; Phillips M; Grulke C; Yoon M; Young B; McDougall R; Leonard J; Lu J; Lefew W; Tan YM
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):689-98. PubMed ID: 26545325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advancing exposure characterization for chemical evaluation and risk assessment.
    Cohen Hubal EA; Richard A; Aylward L; Edwards S; Gallagher J; Goldsmith MR; Isukapalli S; Tornero-Velez R; Weber E; Kavlock R
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):299-313. PubMed ID: 20574904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2,4-D exposure and risk assessment: comparison of external dose and biomonitoring based approaches.
    Hays SM; Aylward LL; Driver J; Ross J; Kirman C
    Regul Toxicol Pharmacol; 2012 Dec; 64(3):481-9. PubMed ID: 23017741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study.
    Sohn MD; McKone TE; Blancato JN
    J Expo Anal Environ Epidemiol; 2004 May; 14(3):204-13. PubMed ID: 15141149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving exposure assessment by monitoring human tissues for toxic chemicals.
    Pirkle JL; Needham LL; Sexton K
    J Expo Anal Environ Epidemiol; 1995; 5(3):405-24. PubMed ID: 8814778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomonitoring for occupational health risk assessment (BOHRA).
    Manno M; Viau C; ; Cocker J; Colosio C; Lowry L; Mutti A; Nordberg M; Wang S
    Toxicol Lett; 2010 Jan; 192(1):3-16. PubMed ID: 19446015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding population and individual risk assessment: the case of polychlorinated biphenyls.
    Shields PG
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):830-9. PubMed ID: 16702358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomonitoring Equivalents for triclosan.
    Krishnan K; Gagné M; Nong A; Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):10-7. PubMed ID: 20541577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions.
    Aylward LL; Kirman CR; Blount BC; Hays SM
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):33-44. PubMed ID: 20685286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uses and issues of biomonitoring.
    Needham LL; Calafat AM; Barr DB
    Int J Hyg Environ Health; 2007 May; 210(3-4):229-38. PubMed ID: 17157561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Children's exposure to environmental pollutants and biomarkers of genetic damage. I. Overview and critical issues.
    Neri M; Bonassi S; Knudsen LE; Sram RJ; Holland N; Ugolini D; Merlo DF
    Mutat Res; 2006 Jan; 612(1):1-13. PubMed ID: 16002329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shellfish and residual chemical contaminants: hazards, monitoring, and health risk assessment along French coasts.
    Guéguen M; Amiard JC; Arnich N; Badot PM; Claisse D; Guérin T; Vernoux JP
    Rev Environ Contam Toxicol; 2011; 213():55-111. PubMed ID: 21541848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collection and use of exposure data from human milk biomonitoring in the United States.
    Fenton SE; Condon M; Ettinger AS; LaKind JS; Mason A; McDiarmid M; Qian Z; Selevan SG
    J Toxicol Environ Health A; 2005 Oct; 68(20):1691-712. PubMed ID: 16176916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomonitoring Equivalents for bisphenol A (BPA).
    Krishnan K; Gagné M; Nong A; Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):18-24. PubMed ID: 20541576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects from environmental Mn exposures: a review of the evidence from non-occupational exposure studies.
    Hudnell HK
    Neurotoxicology; 1999; 20(2-3):379-97. PubMed ID: 10385898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.